4//SEC Filing
Kendrick Charles Morgan JR 4
Accession 0001156039-25-000035
CIK 0001156039other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:52 PM ET
Size
12.1 KB
Accession
0001156039-25-000035
Insider Transaction Report
Form 4
Kendrick Charles Morgan JR
EVP & President, Commercial
Transactions
- Tax Payment
Common Stock
2025-03-03$395.50/sh−2,221$878,406→ 7,089 total - Award
Common Stock
2025-03-03+3,686→ 13,620 total - Award
Employee Stock Option (Right to Buy)
2025-03-03+10,828→ 10,828 totalExercise: $395.50Exp: 2035-03-03→ Common Stock (10,828 underlying) - Award
Common Stock
2025-03-03+2,845→ 9,934 total - Sale
Common Stock
2025-03-05$396.30/sh−3,504$1,388,635→ 10,116 total
Footnotes (6)
- [F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- [F2]Represents restricted share units. Restrictions lapse as follows: 948 shares each on 3/3/2026 and 3/3/2027, and 949 shares on 3/3/2028.
- [F3]Represents performance based restricted share units. Restrictions lapse on 3/3/2025.
- [F4]This transaction was executed in multiple trades, each at the same price of $396.30.
- [F5]Balance includes 22.89 shares acquired on December 20, 2024 through a dividend reinvestment plan.
- [F6]The option represents a right to purchase a total of 10,828 shares, and is exercisable in three annual installments, with two installments of 3,609 shares each and one installment of 3,610 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.
Documents
Issuer
Elevance Health, Inc.
CIK 0001156039
Entity typeother
Related Parties
1- filerCIK 0001887908
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:52 PM ET
- Size
- 12.1 KB